NICE publishes evidence summaries

NICE has published some more of its new ‘evidence summaries’. These are not formal NICE guidance but critical reviews of the available evidence to aid decision making. In the ‘unlicensed/off-label medicines’ series, NICE has recently published evidence summaries for: Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin and Chronic anal fissure: 2% topical diltiazem hydrochloride. In the ‘new medicines’ series, it has looked at aclidinium bromide and glycopyrronium bromide for chronic obstructive pulmonary disease and lixisenatide for Type 2 diabetes.